Posts by John

New prediction markets now allow bets on FDA approvals and clinical trial outcomes. Discover the implications of this shift for medical research and finance.

Kalshi is now offering prediction markets for FDA decisions and clinical trial results, allowing users to trade on the outcomes of drug development milestones.

Dassault Systèmes is reportedly in talks to acquire ArisGlobal. Discover how this move could reshape clinical trial tech, AI, and drug development efficiency.

Dassault Systèmes is in talks to acquire clinical trial software firm ArisGlobal. Discover how this potential deal could reshape the digital health landscape.

Boston Children’s Hospital and OpenEvidence partner to study AI’s impact on clinical care, focusing on patient safety, algorithmic accuracy, and efficacy.

Dassault Systèmes is reportedly in talks to acquire a $2B clinical trial software firm, signaling a major push into life sciences and drug research tech.

Discover how IQVIA and industry leaders are revolutionizing U.S. clinical trials using AI, RWD, and decentralized models to accelerate patient access.

New research suggests GLP-1 receptor agonists could reverse advanced fatty liver disease, offering a major breakthrough for MASH and fibrosis treatment.

New prediction markets now allow betting on FDA drug approvals and clinical trial outcomes, signaling a major shift in biopharma financial forecasting.

The FDA has approved Enlicitide, the first oral PCSK9 inhibitor for high cholesterol, offering a breakthrough, non-injectable option for cardiovascular care.